• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    FDA panelists largely endorse Aimmune`s peanut allergy therapy

    ENDPTS

    FDA Allergenic Products Advisory Committee Votes to Aimmune’s PALFORZIA™

    BUSINESSWIRE

    Aimmune to Present AR101 Data at European Academy of Allergy

    BUSINESSWIRE

    Phase III results move Aimmune’s peanut allergy drug closer to EU market

    PHARMA TIMES

    Aimmune drug application confusion leaves investors searching for answers

    BIOPHARMA DIVE

    Aimmune Therapeutics Submits BLA to FDA for AR101

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.